KIAA1370 inhibitors represent a class of chemical compounds designed to selectively interact with and inhibit the function of the KIAA1370 protein, which is encoded by the KIAA1370 gene. The protein itself is an area of ongoing research, with investigations primarily focusing on its cellular roles and molecular mechanisms. The KIAA1370 gene has been identified through high-throughput genomic sequencing efforts and is of interest due to its possible involvement in key biological processes such as protein synthesis, cellular stress responses, and intracellular signaling. However, the exact molecular function of KIAA1370 and its protein product remains incompletely understood, making inhibitors targeting this protein a crucial tool for probing its roles in various cellular pathways. Through inhibition of KIAA1370, researchers are able to study the downstream effects, including potential disruption in protein complexes and alterations in signal transduction networks, providing valuable insights into the protein's biological significance.
The design and development of KIAA1370 inhibitors typically rely on structure-based drug design techniques, where knowledge of the protein's three-dimensional structure helps guide the creation of molecules that can bind specifically to the active or allosteric sites of the KIAA1370 protein. Advances in computational chemistry, molecular docking, and high-throughput screening have facilitated the identification of lead compounds that display high affinity for KIAA1370, with some of these inhibitors demonstrating selective inhibition in cellular and in vitro models. The binding of these inhibitors to KIAA1370 is believed to induce conformational changes or hinder interactions with other cellular proteins, effectively modulating its activity. Continued research on these inhibitors could enhance our understanding of the broader protein networks in which KIAA1370 participates, shedding light on its contributions to cellular homeostasis and its role in critical biological functions such as protein folding, degradation, and cellular signaling pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
ATM Kinase Inhibitor | 587871-26-9 | sc-202963 | 2 mg | $108.00 | 28 | |
A specific ATM kinase inhibitor that blocks its activity, thereby inhibiting the DNA damage response. | ||||||
KU 60019 | 925701-46-8 | sc-363284 sc-363284A | 10 mg 50 mg | $243.00 $1015.00 | 1 | |
An improved analog of KU-55933, offering greater potency and selectivity in inhibiting ATM kinase activity. | ||||||
AZD-0156 | 1821428-35-6 | sc-507529 | 10 mg | $280.00 | ||
A highly selective and orally bioavailable ATM inhibitor, designed for enhanced pharmacokinetic properties. | ||||||
AZ20 | 1233339-22-4 | sc-503186 | 5 mg | $250.00 | 1 | |
A selective inhibitor that targets both ATM and ATR, involved in the response to DNA damage. | ||||||
ATM/ATR Kinase Inhibitor Inhibitor | 905973-89-9 | sc-202964 | 5 mg | $104.00 | 8 | |
Affects ATM and ATR kinase activities, impacting cellular responses to DNA damage and replication stress. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Indirectly affects ATM function by altering autophagy pathways, which can influence DNA repair mechanisms. | ||||||
VE 821 | 1232410-49-9 | sc-475878 | 10 mg | $360.00 | ||
Primarily an ATR inhibitor, but can also indirectly influence ATM activity due to the interplay between ATM and ATR pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A broad-spectrum PI3K inhibitor that also affects ATM and other PIKK family members at higher concentrations. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 5 g 100 g 250 g 1 kg 5 kg | $32.00 $66.00 $95.00 $188.00 $760.00 | 13 | |
Inhibits ATM and ATR at high concentrations by affecting their kinase activities, impacting the DNA damage checkpoint. | ||||||
NU 7441 | 503468-95-9 | sc-208107 | 5 mg | $350.00 | 10 | |
A potent and specific DNA-dependent protein kinase (DNA-PK) inhibitor, which can also indirectly affect ATM-related pathways due to the close interaction between DNA-PK and ATM in DNA repair. | ||||||